NVTR News and Press, Nuvectra Corporation From 02/19/19

PLANO, Texas, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the fourth quarter and full year ended December 31, 2018 on Thursday, February 28, 2019 after market...

Gainers: TMSR Holding Company (NASDAQ: TMSR ) +223%.  Integrated Media Technology (NASDAQ: IMTE ) +104% . Titan Pharmaceuticals (NASDAQ: TTNP ) +34%.  Professional Diversity Network (NASDAQ: IPDN ) +30% . Continental Materials (NYSEMKT: CUO ) +29% . Gravity (NASDAQ: GRVY ) ...

PLANO, Texas, Jan. 31, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced the appointment of Fred B. Parks, PhD, as Chief Executive Officer, effective immediately. Dr. Parks has served as a member of the Company’s ...

PLANO, Texas, Jan. 29, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a medical device company dedicated to neuromodulation, announced today that the U.S. Food and Drug Administration (FDA) has advised that its review of Company’s pre-market approval (PMA) application ...

Nuvectra Corporation (NASDAQ: NVTR ) announces preliminary Q4 and FY18 revenue. More news on: Nuvectra Corporation, Healthcare stocks news, Read more ...

PLANO, Texas, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today preliminary unaudited revenue for the fourth quarter and full year ended December 31, 2018. Preliminary unaudited consolidated revenue in the fo...

PLANO, Texas, Jan. 02, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it has entered into an agreement effective December 31, 2018, to sell its wholly owned subsidiary NeuroNexus Technologies, Inc. (“Neuro...

PLANO, Texas, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it has received U.S. Food and Drug Administration (FDA) head-only MR-conditional approval for the Company’s Algovita SCS system. Sco...

There are 66 stocks in the Russell 3,000 that are up more than 100% year-to-date in 2018. Below is a list of the 40 best performers. As shown, three stocks - NII Holdings (NIHD), Tandem Diabetes (TNDM), and Turtle Beach (HEAR) - are up 1,000%+ year-to-date, meaning they've recorded "10-baggers...

PLANO, Texas, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief Operating Officer & Chief Financial Officer, are scheduled to participate i...